Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain

NCT06325566 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Degenerative Disc Disease

Interventions

DRUG: Rexlemestrocel-L + HA mixture
DRUG: Saline

Sponsor

Mesoblast, Ltd.